Azelastine and Hepatic steatosis - a phase IV clinical study of FDA data

Summary:

Hepatic steatosis is reported as a side effect among people who take Azelastine (azelastine hydrochloride), especially for people who are female, 60+ old, also take Metoprolol Succinate, and have High blood pressure.

The phase IV clinical study analyzes which people have Hepatic steatosis when taking Azelastine. It is created by eHealthMe based on reports of 17,147 people who have side effects when taking Azelastine from the FDA, and is updated regularly.

What is Azelastine?

Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,400 Azelastine users. Check the latest studies of Azelastine.

What is Hepatic steatosis?

Hepatic steatosis (fatty liver disease) is found to be associated with 1,407 drugs and 1,376 conditions by eHealthMe. Check the latest studies of Hepatic steatosis.

On Jul, 17, 2026

17,147 people reported to have side effects when taking Azelastine.
Among them, 34 people (0.2%) have Hepatic steatosis.

Could Azelastine cause Hepatic steatosis?

Among these 34 people:

What is the gender of people who have Hepatic steatosis when taking Azelastine? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Hepatic steatosis when taking Azelastine? *

What are other drugs people take besides Azelastine? *

What are other side effects people have besides Hepatic steatosis? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 38.24%
Pain: 13 people, 38.24%
Back Pain: 10 people, 29.41%
Pain In Extremity: 10 people, 29.41%
High Blood Pressure: 10 people, 29.41%
Sleep Apnea Syndrome: 10 people, 29.41%
Weight Loss: 10 people, 29.41%
Nosebleed (bleeding from nose): 9 people, 26.47%
High Blood Cholesterol: 9 people, 26.47%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 9 people, 26.47%

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 35.29%
Muscle Spasms (muscle contraction): 9 people, 26.47%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 7 people, 20.59%
Asthma: 6 people, 17.65%
Actinic Keratosis (skin disease due to sun exposure): 6 people, 17.65%
Hypersensitivity: 5 people, 14.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 11.76%
Pain: 4 people, 11.76%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 11.76%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Azelastine and have Hepatic steatosis?

- Check whether Hepatic steatosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azelastine:

Azelastine (17,400 reports)

Browse all side effects of Azelastine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic steatosis:

Hepatic steatosis (1,408 drugs)

Browse all the conditions that are associated with Hepatic steatosis:

Hepatic steatosis (1,376 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azelastine hydrochloride (the active ingredients of Azelastine) and Azelastine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.